Presentation, care, coronary intervention and outcomes of patients with NSTEMI according to age: insights from the international prospective ACVC-EAPCI EORP NSTEMI registry.
No Thumbnail Available
All Authors
Nadarajah, R.
Ludman, P.
Laroche, C.
Appelman, Y.
Brugaletta, S.
Budaj, A.
Bueno, H.
Huber, K.
Kunadian, V.
Leonardi, S.
LTHT Author
Nadarajah, Ramesh
Gale, Christopher
Gale, Christopher
LTHT Department
Cardiology
Cardio-Respiratory
Cardio-Respiratory
Non Medic
Publication Date
2024
Item Type
Journal Article
Multicenter Study
Comparative Study
Multicenter Study
Comparative Study
Language
Subject
Subject Headings
Abstract
BACKGROUND: Older people less frequently receive invasive coronary angiography (ICA) for NSTEMI than younger patients. We describe care, ICA data, and in-hospital and 30-day outcomes of NSTEMI by age in a contemporary and geographically diverse cohort.
METHODS: Prospective cohort study including 2947 patients with NSTEMI from 287 centres in 59 countries, stratified by age (>=75 years, n = 761). Quality of care was evaluated based on 12 guideline-recommended care interventions, and data collected on ICA. Outcomes included in hospital acute heart failure, cardiogenic shock, repeat myocardial infarction, stroke/transient ischaemic attack, BARC Type >=3 bleeding and death, as well as 30-day mortality.
RESULTS: Patients aged >=75 years, compared with younger patients, at presentation had a higher prevalence of comorbidities and oral anticoagulation prescription (22.4% vs 7.6%, p < 0.001). Older patients less frequently received ICA than younger patients (78.6% vs 90.6%, p < 0.001) with the recorded reason more often being advanced age, comorbidities or frailty. Of those who underwent ICA, older patients more frequently demonstrated 3-vessel, 4-vessel and/or left main stem coronary artery disease compared to younger patients (49.7% vs 34.1%, p < 0.001) but less frequently received revascularisation (63.6% vs 76.9%, p < 0.001). Older patients experienced higher rates of in-hospital acute heart failure (15.0% vs 8.4%, p < 0.001) and bleeding (2.8% vs 1.3%, p = 0.006), as well as in-hospital and 30-day mortality (3.4% vs 1.3%, p < 0.001; 4.8% vs 1.7%, p < 0.001; respectively), than younger patients.
CONCLUSIONS: Patients aged >=75 years with NSTEMI, compared with younger patients, less frequently received ICA and guideline-recommended care, and had worse short-term outcomes.
Journal
Age & Ageing